Showing 1 - 20 results of 44 for search '"ПАНКРЕАТИЧЕСКАЯ НЕДОСТАТОЧНОСТЬ"', query time: 0.70s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal

    Source: Modern Pediatrics. Ukraine; No. 2(114) (2021): Modern pediatrics. Ukraine; 21-25
    Современная педиатрия. Украина; № 2(114) (2021): Современная педиатрия. Украина; 21-25
    Сучасна педіатрія. Україна; № 2(114) (2021): Сучасна педіатрія. Україна; 21-25

    File Description: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
    Academic Journal

    Source: Meditsinskiy sovet = Medical Council; № 11 (2017); 148-151 ; Медицинский Совет; № 11 (2017); 148-151 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2017-11

    File Description: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/1931/1913; Pandiri AR. Overview of exocrine pancreatic pathobiology. Toxicol Pathol, 2014, 42(1): 207-16.; Bertelli E, Regoli M, Orazioli D, Bendayan M. Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together? Diabetologia, 2001, 44: 575-584.; Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia, 1998, 41: 629-633.; Van Suylichem PTR, Wolters GHJ, Van Schilfgaarde R. Peri-insular presence of collagenase during islet isolation procedures. J Surg Res, 1992, 53: 503-509.; Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut, 1981, 22(2): 158-167.; Stagner JI, Samols E. The vascular order of islet cellular perfusion in the human pancreas. Diabetes, 1992, 41: 93-97.; Quilichini E, Haumaitre C. Implication of epigenetics in pancreas development and disease. Best Pract Res Clin Endocrinol Metab, 2015, 29(6): 883-98.; Shih HP, Wang A, Sander M. Pancreas organogenesis: from lineage determination to morphogenesis. Annu Rev Cell Dev Biol, 2013, 29: 81-105.; Benitez CM, Goodyer WR, Kim SK. Deconstructing pancreas developmental biology. Cold Spring Harb Perspect Biol, 2012, 1: 4(6).; Burcelin R, Thorens B. Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion. Diabetes, 2001, 50: 1282-1289.; Watanabe T, Yaegashi H, Koizumi M, Toyota T, Takahashi T. Changing distribution of islets in the developing human pancreas: a computerassisted three-dimensional reconstruction study. Pancreas, 1999, 18: 349-354.; Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C. et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia, 1998, 41: 452-459.; Bendayan M. Presence of endocrine cells in pancreatic duct. Pancreas, 1987, 2: 393-397.; Яглов В.В., Яглова Н.В. Актуальные проблемы биологии ациноостровковых клеток поджелудочной железы. Вестник Российской академии медицинских наук, 2010, 7: 28-35.; Можейко Л.А. О гетерогенности экзокринного отдела поджелудочной железы и его физиологических резервах. Журнал ГрГМУ, 2009, 4: 66-69.; Shah AU et al. Cyclic AMP accelerates calcium waves in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol, 2008, 294: 1328-1334.; Konturek SJ, Tasler J, Obulowicz W. Characteristics of inhibition of pancreatic secretion by glucagon. Digestion, 1974, 10: 138-149.; Chandra R, Liddle RA. Modulation of pancreatic exocrine and endocrine secretion. Curr Opin Gastroenterol, 2013, 29(5): 517-22.; Schmitz O, Brock B, Rungby J. Amylin agonists: a novel approach in the treatment of diabetes. Diabetes, 2004, 53(Suppl 3): 233-238.; Терещенко И.В., Каюшев П.Е. Секреция грелина у больных, оперированных по поводу желчнокаменной болезни. Хирургия, 2011, 10: 39-42.

  9. 9
  10. 10
    Academic Journal

    Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 1 (2014); 62-65 ; Российский вестник перинатологии и педиатрии; Том 59, № 1 (2014); 62-65 ; 2500-2228 ; 1027-4065 ; undefined

    File Description: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/35/65; Johаnson A.J., Blizzard R.M. A syndrome of congenital aplasia of the alae nasi, deafness, hypothyroidism, dwarfism, absent permanent teeth and malabsorption. J Pediat 1971; 79: 982— 987.; Schussheim A., Davis J., Chrisian T.F. et al. Exocrine insufficiency with congenital anomalies. J Pediat 1976; 89: 782—784.; Day D.W., Israel J.N. Johanson-Blizzard syndrome. Birth Defects 1978; 14: B6: 275—287.; Mardini M.K., Ghandour M., Skati N.A. et al. Johanson- Blizzard syndrome in a large inbred kindred with three involved members. Clin Genet (Copenhangen) 1978; 14: 247—250.; Daentl D.L., Frias J.L., Gilbert E.F.et al. The Johanson- Blizzard syndrome: Case report and autopsy findings. Am J Med Genet 1979; 3: 129—135.; Reichart P., Flatz S., Burdelski R. et al. Ektrodermale Dysplasie und exokrine Pankreasinsuffizienz ein ergeblich bedingtes Syndrom. Deut Zahnaarzl Z 1979; 34: 263—265.; Bresson J.L., Schmitz J., Saudubray J.M. et al. Le syndrome de Johanson-Blizzard. Une autre cause de lipomatose pancreatique. Arch Fr Pediat 1980; 37: 21—24.; Baraitser M., Hodgson S.V. The Johanson-Blizzard syndrome. J Med Genet (London) 1981; 19: 302—303.; Helin I., Jödal U. A syndrome of congenital hypoplasia of the alae nasi, situs inversus, and severe hypoproteinemia in two siblings. J Pediat 1981; 99: 932—934.; Motahashi N., Pruzansky S., Day D. et al. Roentgenocephalometric analysis of craniofacial growth in Johanson-Blizzard syndrome. J Craniofac Genet Dev Biol 1981; 1: 57—72.; Townes P.L., White M.R. Identity of two syndromes: Proteolytic, lipolytic and amylolytic deficiency of the exocrine pancreas with congenital anomalies. Am J Dis Child 1981; 135: 248—50.; Moeschler J.B., Lubinsky M.S. Johanson-Blizzard syndrome with normal intelligence. Am J Med Genet 1985; 22: 69—73.; Zerres K., Holgrave E.A. The Johanson-Blizzard syndrome: Report of a new case with special reference the dentition and review of the literature. Clin Genet (Copenhagen) 1986; 30: 177—183.; Gould NS et al. Johanson-Blizzard syndrome: Clinical and pathological findings in 2 sibs. Am J Med Genet 1989; 33: 194—199.; Hurst J.A., Baraitser M. Johanson-Blizzard syndrome. J Med Genet (London) 1989; 26: 45—48.; Gorlin R.J., Cohen M.M.Jr., Levin L.S. Syndromes of the head and neck. 3rd ed. New York, Oxford 1990; 812—813.; undefined

  11. 11
  12. 12
  13. 13
    Academic Journal
  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal

    Source: Current Pediatrics; Том 12, № 1 (2013); 181-185 ; Вопросы современной педиатрии; Том 12, № 1 (2013); 181-185 ; 1682-5535 ; 1682-5527

    File Description: application/pdf

    Relation: https://vsp.spr-journal.ru/jour/article/view/389/295; Kharlashina Ye. A., Kononenko I. V., Smirnova O. M., Mayo rov A.Yu. Diabetes as a consequence of biliary recurrent pancreatitis. Diabetes. 2011; 2: 121–125.; Shiryayeva L. V., Zelinskaya D. I. Endocrinological pathology and its consequences in children’s health. Children’s hospital. 2011; 3: 50–55.; Andren-Sanberg A., Hardt P. Second Giessen international workshop on interactions of exocrine and endocrine pancreatic diseases (workshop report). JOP. 2008; 9 (4): 541–575.; Keller J., Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005; 54 (Suppl. VI): 1–28.; Lam W. F., Lindeboom M. E., Lamers C. B., Masclee A. Hyperglycemia reduces pancreaticobiliary secretion in response to modified sham feeding in humans. Digestion. 1999; 60 (2): 141–146.; Nair S., Yadav D., Pitchumoni C. S. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am. J. Gastroenterol. 2000; 95 (10): 2795–2800.; Johansson B. B., Torsvik J., Bjorkhang L. et al. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxylesterlipase gene — maturity onset diabetes of the young (CEL–MODY): a protein misfolding disease. J. Biol. Chem. 2011; 286 (40): 34593–34605.; Laass M., Henker J., Thamm K. et al. Exocrine pancreatic insufficiency and its consequences on physical development and metabolism in children and adolescents with type 1 diabetes mellitus. Eur. J. Pediatr. 2004; 163: 681–682.; Belmer S. V., Gasilina T. V. Disorders of pancreatic gland exocrine function in children: diagnostics and ways of correction. Questions of practical Pediatrics. 2009; 4 (4): 60–66.; Bijoor A., Geetha S., Venkatesh T. Faecal fat content in healthy adults by the acid steatocrit method. Ind. J. Clin. Biochem. 2004; 19 (2): 20–22.; Hardt P. D., Hauenschild A., Jaeger C. et al. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig. Dis. Sci. 2003; 48 (9): 1688–1692.; Kazak S. S. Causes, diagnostics and therapy with enzymes of secondary endocrine insufficiency in children and adolescents. Clinical experimental pathology. 2008; 7 (3): 1–20.; Czako L., Hegyi P., Rakonczay Z. et al. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009; 9 (4): 351–359.; Panicot L., Mas E., Thivolet C., Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes. 1999; 48: 2316–2323.; Sierra C., Blasco J., Lopez-Siguero J. et al. Pancreatic fecal elastase in children with type 1 diabetes. J. Pediatr. Gastroenterol. Nutr. 2004; 39 (Suppl. 1): 370.; Luth S., Teyssen S., Forssmann K. et al. Fecal elastase 1 determination: 'gold standard' of indirect pancreatic function tests? Scand. J. Gastroenterol. 2001; 36 (10): 1092–1099.; Soldan W., Henker J., Sprossig C. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children. J. Pediatr. Gastroenterol. Nutr. 1997; 24 (1): 53–55.; Dominguez-Munos J., Hieronymus C., Sauerbruch T., Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am. J. Gastroenterol. 1995; 90 (10): 1834–1837.; Cavalot F., Bonomo K., Perna P. et al. Pancreatic elastase 1 in stools, a marker of exocrine pancreas function, correlates with both residual -cell secretion and metabolic control in type 1 diabetic patients. Diabetes care. 2004; 27 (8): 2052–2054.; Icks A., Haastert B., Giani G., Rathmann W. Low fecal elastase-1 in type 1 diabetes mellitus. Z. Gastroenterol. 2001; 39 (10): 823–830.; Borysiuk M., Dosenko V., Byts I. V. Elastolytic system of the pancreas in modelling diabetes mellitus. Fiziol. Zh. 2002; 48 (5): 17–21.; Parkhomenko L. K., Yeshchenko A. V. Pancreatic insufficiency in children. Modern Pediatrics. 2010; 1 (29): 126–129.; Ewald N., Bretzel R., Fantus I. et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multicentre trial. Diabetes Metab. Res. Rev. 2007; 23 (5): 386–391.; Lowe M. E. Pancreatitis. In: Pancreatic gastrointestinal and liver disease. R. Wyllie, J. Hyams, M. Kay (eds.). Elsevier Saunders, USA. 2011. P. 905–914.

  18. 18
  19. 19
  20. 20